HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA cosmetics reporting program review suggested by CTFA to counter budget cuts.

This article was originally published in The Rose Sheet

Executive Summary

FDA COLOR ADDITIVE PROGRAM CUTS SUGGESTED BY CTFA to help counter spending reductions within the agency's Office of Cosmetics & Colors. In a recent "white paper" sent to FDA lead Deputy Commissioner Michael Friedman, MD, the Cosmetic, Toiletry and Fragrance Association suggests "in light of the large number of personnel involved...FDA may wish to review whether" the color additive batch certification program "continues to represent an appropriate expenditure of agency resources."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel